Other
Dutch Burns Foundation
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
40.0%
2 terminated/withdrawn out of 5 trials
Success Rate
60.0%
-26.5% vs industry average
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 3
2(40.0%)
Phase 4
2(40.0%)
N/A
1(20.0%)
5Total
Phase 3(2)
Phase 4(2)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT01773083Phase 3Terminated
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Role: collaborator
NCT00297752Phase 4Completed
Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing
Role: collaborator
NCT01616043Phase 3Terminated
Glyaderm Clinical Evaluation Multicenter Study
Role: collaborator
NCT01489540Not ApplicableCompleted
Cost-effectiveness of Laser Doppler Imaging in Burn Care
Role: collaborator
NCT00156988Phase 4Completed
The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Role: collaborator
All 5 trials loaded